SmartKem, Inc.

The grade, in three tenses

Headline 3.8 out of ten, 8 of 9 metrics filed and 1 estimated: past 1.9 out of ten, present 2.7 out of ten, future 7.2 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

• Surviving crises (past): 0.2 out of ten. 14 warning events since 2020; the latest 2026-09-14. 2nd percentile among 99 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
• Track record (past): 3.8 out of ten. +49.3% a year over 6 filed years; profitable in 0 of 6. 38th percentile among 93 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
• Shareholder treatment (past): 0.8 out of ten. CrossAssetData estimate 0.8/10, confidence 35 of 100 (one part). 8th percentile among 94 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
• Financial health (present): 1.8 out of ten. Leverage 272%: owes 272¢ per asset dollar. 18th percentile among 95 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
• Industry position (present): 3.5 out of ten. bottom 35% of 97 in its family; net margin -1507.7%. 35th percentile among 97 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
• Leadership (present): 3.2 out of ten. bottom 32% of 66 in its family for leadership; chief executive since 2021. 32nd percentile among 66 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
• Room to expand (future): 6.2 out of ten. top 38% of 94 in its family for room to expand. 62nd percentile among 94 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
• Growth drivers (future): 7.8 out of ten. top 22% of 93 in its family for growth drivers. 78th percentile among 93 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
• Expectations vs reality (future): 8.3 out of ten. top 16% of 88 in its family for expectations against reality. 84th percentile among 88 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).

The filing record

Newest annual report: Form 10-K filed 2026-04-08 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-14 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2025-11-13 (on EDGAR). Newest filing: Form 8-K, 2026-09-21. Filings on record since 2020. Read from EDGAR 2026-10-12.

How the company works

Read from its Form 10-K filed 2026-04-08.

The people

Ian Jenks has run SmartKem as chief executive and president since December 2017 and joined its board in February 2021; the filing credits him with more than 30 years of board level experience in industrial technology. Barbra C. Keck has been chief financial officer since December 2022, and sat on the board from February 2021 to November 2022, coming from the same job at Deverra Therapeutics. Jonathan Watkins became chief operating officer in March 2025, after consulting for the company from July 2024; he had run Impression Technologies Limited from August 2016 to June 2024, and that company entered voluntary liquidation in June 2024. Simon Ogier has been chief technology officer since June 2019 and held the same post before that at NeuDrive Limited, another organic semiconductor materials developer. [1, 2, 3, 4, 5]

The board is small and long serving. Klaas de Boer has been a director since February 2021 and sat on SmartKem Limited's own board from 2017; he was managing partner of the venture capital firm Entrepreneurs Fund Management LLP from January 2008 until June 2021. Steven DenBaars, a professor of materials at the University of California, Santa Barbara, joined in June 2022. Melisa A. Denis joined in November 2023, after a career as a partner at KPMG from 1998 to October 2020. Sriram Peruvemba joined in July 2023 and had advised the company as a consultant since September 2019, which is why the board counts him, along with Jenks, as not independent. [6, 7, 8, 9, 10, 11]

This is a very small company. As of April 1, 2026 it counted 28 full time employees and one part time employee across the United Kingdom, Taiwan and the United States, with no collective bargaining agreement. Selling is thinner still: a direct sales force of one employee in Taiwan, helped by two technology transfer engineers and sales representation in China, with two more employees in Taiwan supporting the work at the Industrial Technology Research Institute. Fourteen people have filed Forms 3, 4 and 5 as officers or directors since the record begins, nine of them in the last fifteen months. [12, 13, 14, 15]

How it operates

SmartKem makes materials, not devices. Its TRUFLEX semiconductor polymers are organic materials that print at low temperature onto existing manufacturing lines, which the company puts forward as a way to build displays using MicroLED, liquid crystal and AMOLED technology, and also for advanced chip packaging, sensors and logic. The materials ship as a set of stable liquid inks, each ink forming one layer of the device, tuned to the performance the customer specifies and delivered with a written process of record telling the customer how to use them. Alongside the full organic thin film transistor stack, which is the switching layer behind each pixel, customers evaluate single interlayer materials as redistribution layers, pixel definition layers, permanent resists and organic dielectric layers. [16, 17, 18]

The money is not yet product money. Revenue is made up of sales of TRUFLEX inks and demonstration products plus fees earned under joint development agreements, and it is booked when each ink or demonstrator ships. In 2025 it came to 697 thousand dollars, against 82 thousand in 2024, on a cost of revenue of 272 thousand. Two buyers accounted for 60% and 19% of the year's revenue between them; in 2024 no customer reached 10%. Material is supplied in package sizes from 100ml up to several liters, all from the Manchester site, with a certificate of analysis and design consultancy attached, quantities that suit evaluation rather than production. [19, 20, 21, 22, 23, 24, 25]

The customers it aims at are large consumer electronics companies in Asia: Taiwan, South Korea, Japan and China. The company says its first customers will be in those four countries, and that it is also working directly with original equipment manufacturers in North America, Europe and elsewhere in Asia that can require their own suppliers to use its materials. It expects the path from first contact to a purchase order to take about 12 to 24 months, and says it must spend heavily through that period with no assurance of an order at the end. [26, 27, 28]

Everything is made in one place. Materials are designed at the research and development site in Manchester, prototyping runs at the Centre for Process Innovation in Sedgefield, and a field application office sits in Hsinchu, Taiwan, next to the Industrial Technology Research Institute. The active materials, the ones needing tight process control, are synthesized either in house or by certified outside suppliers and then formulated into inks; the passive interlayer inks use commercially available intermediates. Both are presently blended in the Manchester formulation facility, with a larger scale base layer material from an outside contractor under evaluation. The company reports no supply shortages in the materials behind its inks, but it depends on third party facilities, the Industrial Technology Research Institute among them, for prototyping and for developing the commercial scale manufacturing processes it does not own. [29, 30, 31, 32, 33]

The specifics

What changed most is what the company owns. In the first quarter of 2026 SmartKem transferred its patent portfolio to a third party as part of a set of financing transactions, and what it says it still holds is its process and formulation intellectual property, codified in 40 trade secrets. The transfer came out of settlement agreements with the holders of earlier notes: the patents, the applications, their continuations and foreign counterparts, and the right to sue for past, present and future infringement were all assigned to SmartKem IP LLC, a Delaware company. SmartKem also agreed to keep a designated patent liaison employed for six months after the settlement took effect, to give those holders information and support on the assigned property. The filing says the company is continuing a review of its strategy, weighing its display prototyping work, its materials formulation work and whether to add new materials. [34, 35, 36]

The competition is mostly not organic at all. The established way to make display backplanes is inorganic: amorphous silicon for liquid crystal displays, the metal oxide IGZO for large area OLED televisions, low temperature polycrystalline silicon for high resolution phones. All of those run hot, which the company argues forces costly substrates, especially where the surface is plastic. Among makers of organic inks it names BASF SE, Merck KGaA and Sumitomo Chemical Co., Ltd., whose polymeric semiconductors it says process well but carry lower mobility than its own polycrystalline blend. The filing also grants that many potential competitors could have longer operating histories, deeper product ranges, larger customer bases and substantially greater resources. [37, 38, 39]

Regulation here is chemical regulation. Every new chemical is assessed under the Control of Substances Hazardous to Health rules before any practical work with it starts, and materials are screened against the banned and restricted lists that display manufacturers publish. Safety data sheets for shipped products are written by an outside service provider, and the filing says the formulated products contain no materials restricted in the United Kingdom. One material is an exception: the organic gate insulator is fluorinated and spun from a fluorosolvent listed under regulation (EC) No 428/2009, so exporting formulations can require a standard individual export license, obtained through the United Kingdom's SPIRE system. [40, 41, 42, 43]

The shell and the business met in 2021. SmartKem Limited was incorporated in England and Wales on July 21, 2008. Parasol Investments Corporation was incorporated in Delaware on May 13, 2020 and was a registered shell company with no business plan or purpose of its own. On February 23, 2021 the two were joined in an exchange of shares, SmartKem Limited became a wholly owned subsidiary, and the parent took the SmartKem name. The company has filed with the SEC since 2020, and its home address on the record is Manchester. [44, 45, 46, 47]

What drives growth, line by line

Revenue is tiny and lumpy. It was 697 thousand dollars in 2025 against 82 thousand in 2024, and the filing attributes the rise to two things: 107 thousand more from selling demonstrator products to potential partners as marketing widened, and 508 thousand from several joint development agreements that were completed during the year. Cost of revenue rose with it, to 272 thousand from 32 thousand, on more units sold and the costs of those completed agreements. [19, 21, 22]

Demonstrator products. The smaller of the two movements: 107 thousand dollars more than the year before, which the company puts down to selling demonstrator units to potential partners as it expanded its marketing. Demonstrators are the working samples a materials supplier hands a prospective customer, and the filing says the revenue on each is recognized when it ships. [21, 24]

Joint development agreements. The larger movement, 508 thousand dollars, came from several joint development agreements completed in 2025. These are the collaborations the company has been signing for years: RiTdisplay in Taiwan, for an AMOLED display built on organic transistors; Tianma Microelectronics, for microarray biochips; Chip Foundation, for MicroLED backlights behind liquid crystal displays; AUO, for rollable transparent MicroLED displays; Manz Asia, for chip packaging. The first sale of TRUFLEX materials, to Chip Foundation under that co-development agreement, closed in January 2025. In December 2025 SmartKem added a proof of concept agreement with what it describes only as a leading global consumer electronics company, for MicroLED wearables. [21, 48, 49, 50, 51, 52, 53, 54]

Two customers carried the year. Customer A and Customer B, neither of them named, made up 60% and 19% of 2025 revenue; in 2024 no customer reached 10% of the total. At revenue of this size a single completed agreement is enough to produce both the concentration and the growth. [23, 19]

Spending went the other way. Operating expenses rose by 2.7 million dollars to 14.2 million in 2025, from 11.5 million, with research and development up 1.9 million to 7.0 million on the cost of prototyping, and general and administrative up 1.1 million to 7.4 million from 6.3 million on professional service fees. Government research grants and research and development tax credits brought in 1.0 million in each of the two years. The net loss was 10.5 million against 10.3 million the year before. [55, 56, 57, 58, 59, 19]

What comes next, in the company's own words: it says cash and cash equivalents of 0.4 million dollars at the end of 2025, down from 7.1 million a year earlier, will not be sufficient to fund its operating expenses and capital expenditure for the next twelve months, and that it will require more capital to continue. It lists expected cash payments over the coming year of 2.6 million for accounts payable and accrued expenses, 271 thousand for lease liabilities and 1.1 million for the note payable. Its stated plan is to finance working capital through some combination of equity offerings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements. The filing states plainly that there is substantial doubt the company will be able to pay its obligations as they fall due, and that management's plans do not relieve that doubt. [60, 61, 62, 63, 64]

What the desk infers (inferred, not filed)

• Customer A, the buyer behind three fifths of 2025 revenue, was most likely a joint development partner paying for a completed program, not a manufacturer buying ink for production. Because: Of the rise in revenue, 508 thousand dollars came from several joint development agreements completed in 2025, against 107 thousand from demonstrator products, so development work accounts for most of the year's total. [21] In 2024, when no such agreement completed, no single customer reached 10% of revenue. [23] The company expects the path from first contact to a purchase order to run about 12 to 24 months, and it supplies material in package sizes from 100ml to several liters, which are evaluation quantities. [28, 25] Its collaboration partners over the period include RiTdisplay, Tianma Microelectronics, Chip Foundation, AUO and Manz Asia, and the first sale of TRUFLEX materials went to Chip Foundation under a co-development agreement. [48, 49, 50, 52, 53] Confidence 65 of 100. Wrong if: A filing or a revenue note that attributes Customer A's revenue to product sales of TRUFLEX inks in production quantities rather than to a development or collaboration agreement.
• Revenue here counts how many development programs finished in a year rather than how much material customers consume, so a large move in the figure says little about whether the technology is being adopted. Because: Revenue is made up of ink sales, demonstration products and fees from joint development agreements, and each ink or demonstrator is booked when it ships. [20, 24] The 2025 jump came from agreements completed in 2025 and from demonstrator sales, not from repeat product orders. [21] Material ships in package sizes from 100ml to several liters with a certificate of analysis and design consultancy attached, the pattern of qualification work rather than of supply. [25] The company expects a sales cycle of about 12 to 24 months and says it must spend through it with no assurance of an order. [28] Confidence 75 of 100. Wrong if: A year in which sales of TRUFLEX inks to a manufacturer running production, rather than development agreements and demonstrators, make up most of revenue.
• With the patent portfolio assigned away, what protects SmartKem's position is secrecy and the small group of people who hold the process knowledge, which makes keeping its technical staff the company's main defense. Because: The patent portfolio was transferred to a third party in the first quarter of 2026; what the company says it still owns is process and formulation intellectual property codified in 40 trade secrets. [34] The assignment carried the patents, the applications, their continuations and foreign counterparts, and the right to sue for past, present and future infringement, to SmartKem IP LLC. [35] The company agreed to keep a designated patent liaison employed for six months after the settlement to give the holders information and support on the assigned property, so the knowledge needed to work those patents sat with its own staff. [36] It counted 28 full time employees and one part time employee across three countries as of April 1, 2026. [12] Its chief technology officer has over 19 years in organic semiconductors and is a co-inventor on a number of patent families. [65] Confidence 70 of 100. Wrong if: A filing showing SmartKem holds a license back to the assigned patents on terms that let it practice and enforce them, or a new portfolio of patent applications filed in its own name after the assignment.

Sources

1. SmartKem, Inc., Form 10-K filed 2026-04-08: “Ian Jenks has served as our Chief Executive Officer and President since December 2017 and as a member of our board of directors since February 2021. Mr. Jenks has more than 30 years of board-level experience in the industrial technology industry and has served as chief executive officer of companies operating in the United States and Europe.”
2. SmartKem, Inc., Form 10-K filed 2026-04-08: “Barbra C. Keck has served as our Chief Financial Officer since December 2022 and has served as a member of our board of directors from February 2021 to November 2022. From February 2021 to December 2022, Ms. Keck served as the chief financial officer of Deverra Therapeutics, Inc., a developer of cell therapies.”
3. SmartKem, Inc., Form 10-K filed 2026-04-08: “Jonathan Watkins has served as our Chief Operating Officer since March 2025. From July 2024 until his appointment as the Company’s Chief Operating Officer, Mr. Watkins served as a consultant to our company.”
4. SmartKem, Inc., Form 10-K filed 2026-04-08: “From August 2016 through June 2024, Mr. Watkins served as the chief executive officer of Impression Technologies Limited (“ITL”), where he led the development, licensing and scaling of a novel aluminum light-weighting technology for automotive, aerospace and consumer electronics markets, as well as securing manufacturing partners in Europe, China and North America. ITL entered voluntary liquidation in June 2024.”
5. SmartKem, Inc., Form 10-K filed 2026-04-08: “Simon Ogier, Ph.D. has served as our Chief Technology Officer since June 2019. From August 2015 to June 2019 Dr. Ogier was CTO at NeuDrive Limited, a developer of organic semiconductor materials for sensor and other electronic applications”
6. SmartKem, Inc., Form 10-K filed 2026-04-08: “Klaas de Boer has served as a member of our board of directors since February 2021 and has served as a member of the board of directors of SmartKem Limited since 2017. From January 2008 until June 2021, Mr. de Boer served as the managing partner of Entrepreneurs Fund Management LLP, a venture capital firm.”
7. SmartKem, Inc., Form 10-K filed 2026-04-08: “Steven DenBaars has served as a member of our board of directors since June 2022. Professor DenBaars is a Distinguished Professor of Materials and Co-Director of the Solid-State Lighting and Energy Electronics Center at University of California, Santa Barbara.”
8. SmartKem, Inc., Form 10-K filed 2026-04-08: “Melisa A. Denis has served as a member of our board of directors since November 2023.”
9. SmartKem, Inc., Form 10-K filed 2026-04-08: “Ms. Denis previously served as a partner at KPMG from 1998 to October 2020”
10. SmartKem, Inc., Form 10-K filed 2026-04-08: “Sriram Peruvemba has served as a member of our board of directors since July 2023. From September 2019 until his appointment to the Board, Mr. Peruvemba served as a consultant to the Company.”
11. SmartKem, Inc., Form 10-K filed 2026-04-08: “our board of directors has determined that all current members of the board of directors are independent, except Mr. Jenks and Mr. Peruvemba.”
12. SmartKem, Inc., Form 10-K filed 2026-04-08: “As of April 1, 2026, we had 28 full-time employees and one part-time employee located in the United Kingdom, Taiwan, and United States. We are not a party to any collective bargaining agreements.”
13. SmartKem, Inc., Form 10-K filed 2026-04-08: “We have a direct sales force consisting of one employee located in Taiwan, assisted by two technology transfer engineers, and sales representation in China.”
14. SmartKem, Inc., Form 10-K filed 2026-04-08: “We have two employees supporting this work in Taiwan in addition to support from our staff in the UK.”
15. The record on this page: the officers and directors who file Forms 3, 4 and 5 (the SEC's insider data sets)
16. SmartKem, Inc., Form 10-K filed 2026-04-08: “Our TRUFLEX® semiconductor polymers enable low-temperature printing processes that are compatible with existing manufacturing infrastructure to deliver low-cost, high-performance displays. Our semiconductor platform can be used in a range of display technologies, including MicroLED, liquid crystal display (“LCD”), and AMOLED, as well as in applications in advanced computer and artificial intelligence chip packaging, sensors, and logic.”
17. SmartKem, Inc., Form 10-K filed 2026-04-08: “We supply our advanced materials as a set of stable liquid inks, with each ink forming a separate layer of the device. Each of the inks forming these layers has been carefully designed to achieve the device performance and electrical stability specified by the customer. We supply the ink set with a detailed process of record (“POR”) for producing the desired device.”
18. SmartKem, Inc., Form 10-K filed 2026-04-08: “In addition to supplying our organic thin-film transistor (“OTFT”) stack materials as a package, prospective customers also evaluate the use of our range of interlayer materials as single layers in new and existing chip and display products (in so-called advanced semiconductor packaging). The interlayer materials are being tested as redistribution layers, pixel definition layers, permanent resists, and organic dielectric layers”
19. The record on this page: the filed annual figures (EDGAR's company facts)
20. SmartKem, Inc., Form 10-K filed 2026-04-08: “Our revenue consists of revenue from the sale of TRUFLEX® inks and demonstration products and revenue earned from various joint development agreements.”
21. SmartKem, Inc., Form 10-K filed 2026-04-08: “Revenues were $697 thousand for the year ended December 31, 2025, compared to $82 thousand for the same period of 2024. The increase in revenues resulted primarily from an increase of $107 thousand in the sale of demonstrator products to potential partners, as we sought to expand our marketing efforts and $508 thousand related to several joint development agreements that were completed in 2025.”
22. SmartKem, Inc., Form 10-K filed 2026-04-08: “Cost of revenue was $272 thousand for the twelve months ended December 31, 2025, compared to $32 thousand for the same period of 2024, primarily as a result of a unit increase in the number of products sold during 2025 and costs associated with the completed joint development agreements during 2025.”
23. SmartKem, Inc., Form 10-K filed 2026-04-08: “Customer A and B comprised of 60% and 19% of revenue for the year ended December 31, 2025. No customers comprised over 10% of revenue for the year ended December 31, 2024.”
24. SmartKem, Inc., Form 10-K filed 2026-04-08: “The Company derives its revenues primarily from sales of TRUFLEX® inks and of demonstrator units to customers evaluating organic semiconductor technology. The transaction price is stated in each customer agreement and is allocated to a single performance obligation. Revenue is recognized upon shipment of each TRULFEX® ink or demonstrator, at a point in time.”
25. SmartKem, Inc., Form 10-K filed 2026-04-08: “Products have been scaled up for formulated ink supply to customers in package sizes ranging from 100ml to several liters, all supplied from our Manchester facility. These are supplied with a certificate of analysis (CoA) and POR, alongside device and design consultancy to ensure successful technology transfer.”
26. SmartKem, Inc., Form 10-K filed 2026-04-08: “The majority of our target customers are large consumer electronics companies based in Asia (Taiwan, South Korea, Japan and China). We believe that these customers are seeking to create novel, higher added value electronics products.”
27. SmartKem, Inc., Form 10-K filed 2026-04-08: “We believe that our initial customers will be located in Taiwan, South Korea, Japan and China but we are also directly working with original equipment manufacturers (“OEMs”) located in North America, Europe and elsewhere in Asia who have the ability to require their suppliers to use our materials.”
28. SmartKem, Inc., Form 10-K filed 2026-04-08: “We expect that the sales cycle described above will take approximately 12 to 24 months. During that period, we will be required to incur significant expenses without any assurance that a customer order will be obtained. Accordingly, we face a significant risk that we will incur those expenses without ever making a sale.”
29. SmartKem, Inc., Form 10-K filed 2026-04-08: “We design and develop our materials at our research and development facility in Manchester, UK, and provide prototyping services at the Centre for Process Innovation in Sedgefield, UK. We also operate a field application office in Hsinchu, Taiwan, in close proximity to our collaboration partner, The Industrial Technology Research Institute of Taiwan.”
30. SmartKem, Inc., Form 10-K filed 2026-04-08: “Our active materials generally require high levels of process and product control, and therefore these are synthesized from start to end by us or a third party that has met certain certification requirements and then formulated by us into organic semiconductor inks. We validate active components internally before use. Our passive interlayer inks use a range of commercially available intermediates, formulated to our specifications to meet differing end-use performance parameters depending on the intended use.”
31. SmartKem, Inc., Form 10-K filed 2026-04-08: “The active and passive interlayer inks are presently manufactured internally in our formulation facility located in Manchester, U.K. We are also evaluating a base layer material manufactured on a larger scale by a third-party contractor.”
32. SmartKem, Inc., Form 10-K filed 2026-04-08: “We have not experienced any supply shortages with respect to the materials used to formulate our proprietary inks.”
33. SmartKem, Inc., Form 10-K filed 2026-04-08: “We rely on third-party facilities, including the Industrial Technology Research Institute ("ITRI") in Taiwan, for prototyping and the development of commercial-scale manufacturing processes for our TRUFLEX® materials.”
34. SmartKem, Inc., Form 10-K filed 2026-04-08: “These included the transfer of our patent portfolio to a third party. The company still owns its process and formulation intellectual property as codified in 40 trade secrets. As previously disclosed the company is continuing to conduct a review of its strategy. In particular it is evaluating its display prototyping activities, its materials formulation activities and the possibility of adding new materials to its portfolio.”
35. SmartKem, Inc., Form 10-K filed 2026-04-08: “the Company agreed to assign, transfer, and convey to SmartKem IP LLC, a Delaware limited liability company, certain of the Company's right, title, and interest in and to certain patents and patent applications, together with all continuations, continuations-in-part, divisionals, reissues, reexaminations, extensions, foreign counterparts, and all rights to sue for past, present, and future infringement thereof.”
36. SmartKem, Inc., Form 10-K filed 2026-04-08: “The Company also agreed to maintain the employment of a designated patent liaison for a period of six (6) months following the effective date of the Settlement Agreements to provide the Holders with information, assistance, and support relating to the Assigned IP.”
37. SmartKem, Inc., Form 10-K filed 2026-04-08: “a-Si technology is an inorganic process widely used in the manufacture of backplanes for LCDs. More recent developments in inorganic semiconductors include the use of the metal oxide indium gallium zinc oxide (“IGZO”) for backplanes for large-area OLED TVs and low temperature polycrystalline silicon (“LTPS”) for high-resolution cell phones. All of these inorganic processes are operated at high temperatures and therefore require high-cost substrates, particularly where processing on plastic is required.”
38. SmartKem, Inc., Form 10-K filed 2026-04-08: “A number of competitors have engaged in the development of organic inks. However, these competitors either opt to use polymeric semiconductors (BASF SE, Merck KGaA and Sumitomo Chemical Co., Ltd.) that process well but have lower mobility than the polycrystalline organic materials in our TRUFLEX® materials, or polycrystalline semiconductors that have high mobility but relatively poor uniformity when processed.”
39. SmartKem, Inc., Form 10-K filed 2026-04-08: “Many of our potential competitors could have substantial competitive advantages, such as greater name recognition, longer operating histories, broader and deeper product portfolios, larger customer bases, and substantially greater financial and other resources, as well as larger-scale manufacturing operations.”
40. SmartKem, Inc., Form 10-K filed 2026-04-08: “All new chemicals we obtain are evaluated at the time of order and a Control of Substances Hazardous to Health (“COSHH”) assessment is performed prior to commencement of any practical work with these materials.”
41. SmartKem, Inc., Form 10-K filed 2026-04-08: “Materials are also screened against lists of banned and restricted materials provided by display manufacturers. Any material present on the display manufacturers banned list would not be used in formulated product.”
42. SmartKem, Inc., Form 10-K filed 2026-04-08: “We work with a third-party service provider to create safety data sheets for our formulated products that are shipped to customers and other end users. Our formulated products contain no materials that are restricted in the U.K. and no permissions or exemptions are required.”
43. SmartKem, Inc., Form 10-K filed 2026-04-08: “Our OGI material is fluorinated and spun from a fluorosolvent listed under regulation (EC) No 428/2009 of 5 May 2009 under section 1C006d. Export of formulations may require a Standard individual export license to be applied for, and end use declaration made by the customer. These can be obtained through the U.K.’s SPIRE system.”
44. SmartKem, Inc., Form 10-K filed 2026-04-08: “We were incorporated as Parasol Investments Corporation in the State of Delaware on May 13, 2020. SmartKem Limited was incorporated under the laws of England and Wales on July 21, 2008. On February 23, 2021, we completed an exchange with SmartKem Limited and the former shareholders of SmartKem Limited (the “Exchange”) pursuant to which substantially all of the equity interests in SmartKem Limited were exchanged for shares of our common stock, and SmartKem Limited became our wholly owned subsidiary.”
45. SmartKem, Inc., Form 10-K filed 2026-04-08: “Prior to the Exchange, Parasol Investments Corporation was a “shell” company registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), with no specific business plan or purpose until it began operating the business of SmartKem Limited following the closing of the Exchange.”
46. The record on this page: the filing record (the EDGAR submissions feed)
47. The record on this page: the filing record (the EDGAR submissions feed)
48. SmartKem, Inc., Form 10-K filed 2026-04-08: “In 2023, we entered into a technology transfer agreement with RiTdisplay, pursuant to which the parties commenced a joint project to develop the world’s first commercially ready active-matrix OLED display using OTFT technology.”
49. SmartKem, Inc., Form 10-K filed 2026-04-08: “In February 2024, we entered into a joint development agreement with Tianma Microelectronics Co., Ltd. to integrate our organic thin-film transistor technology with Tianma’s oxide transistors to develop OTFT-based microarray biochips.”
50. SmartKem, Inc., Form 10-K filed 2026-04-08: “In September 2024, we entered into a joint development agreement with Chip Foundation to co-develop a new generation of MicroLED backlight technology for Liquid Crystal Displays.”
51. SmartKem, Inc., Form 10-K filed 2026-04-08: “In November 2024, we entered into a collaboration agreement with AUO to develop a new generation of rollable, transparent MicroLED displays using our technology.”
52. SmartKem, Inc., Form 10-K filed 2026-04-08: “In May 2025, we entered into a collaboration agreement with Manz Asia for advanced computer and artificial intelligence chip packaging, and in July 2025 we entered into a preliminary joint development agreement with Manz Asia in furtherance of that collaboration.”
53. SmartKem, Inc., Form 10-K filed 2026-04-08: “In January 2025, we completed the first sale of our TRUFLEX® materials to Chip Foundation under our co-development agreement.”
54. SmartKem, Inc., Form 10-K filed 2026-04-08: “In December 2025, we entered into a proof-of-concept agreement with a leading global consumer electronics company for the development of MicroLED wearables.”
55. SmartKem, Inc., Form 10-K filed 2026-04-08: “Operating expenses increased by $2.7 million to $14.2 million for the year ended December 31, 2025, compared to $11.5 million for the comparable period of 2024.”
56. SmartKem, Inc., Form 10-K filed 2026-04-08: “increased by $1.9 million to $7.0 million for the year ended December 31, 2025, compared to $5.1 million for the same period of 2024. The increase in research and development expenses was mainly due to the increase in the cost of our prototyping activities.”
57. SmartKem, Inc., Form 10-K filed 2026-04-08: “General and administrative expense, which represented 51.9% and 55.0% of our total operating expenses for the twelve months ended December 31, 2025 and 2024, respectively, increased by $1.1 million to $7.4 million for year ended December 31, 2025 as compared to $6.3 million for the same period in 2024. This increase was mainly due to increased professional service fees.”
58. SmartKem, Inc., Form 10-K filed 2026-04-08: “Net loss was $10.5 million for the year ended December 31, 2025, an increase of $0.2 million, compared to a net loss of $10.3 million for the year ended December 31, 2024.”
59. SmartKem, Inc., Form 10-K filed 2026-04-08: “Other operating income was $1.0 million for both years ended December 31, 2025 and 2024 and is comprised primarily of research grants and research and development tax credits.”
60. SmartKem, Inc., Form 10-K filed 2026-04-08: “As of December 31, 2025, our cash and cash equivalents were $0.4 million compared with $7.1 million as of December 31, 2024.”
61. SmartKem, Inc., Form 10-K filed 2026-04-08: “We expect that our cash and cash equivalents of $0.4 million as of December 31, 2025 will not be sufficient to fund our operating expenses and capital expenditure requirements for the next 12 months and that we will require additional capital funding to continue our operations and research development activity thereafter.”
62. SmartKem, Inc., Form 10-K filed 2026-04-08: “Our expected cash payments over the next twelve months include (a) $2.6 million to satisfy accounts payable and accrued expenses, (b) $271 thousand to satisfy the lease liabilities and (c) $1.1 million to satisfy the note payable.”
63. SmartKem, Inc., Form 10-K filed 2026-04-08: “Until such time, if ever, as we can generate sufficient cash through revenue, management’s plans are to finance our working capital requirements through a combination of equity offerings, debt financings, collaborations, strategic alliances and marketing, distribution or licensing arrangements.”
64. SmartKem, Inc., Form 10-K filed 2026-04-08: “There is substantial doubt that we will be able to pay our obligations as they fall due, and this substantial doubt is not alleviated by management plans.”
65. SmartKem, Inc., Form 10-K filed 2026-04-08: “Dr. Ogier has over 19 years of experience developing high performance organic semiconductors for transistor applications. Dr. Ogier has co-authored a number of journal articles and is a co-inventor on a number of patents families.”

Who runs it

Jenks, Ian (Chairman & CEO); Keck, Barbra (Chief Financial Officer); Denbaars, Steven (director); De, Boer Klaas (director); Denis, Melisa (director); Peruvemba, Sriram Krishnamurthy (director). 6 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.